Jean‐Michel Vernier

1.5k total citations
29 papers, 869 citations indexed

About

Jean‐Michel Vernier is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Jean‐Michel Vernier has authored 29 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 5 papers in Oncology. Recurrent topics in Jean‐Michel Vernier's work include Neuroscience and Neuropharmacology Research (15 papers), Receptor Mechanisms and Signaling (12 papers) and Nicotinic Acetylcholine Receptors Study (6 papers). Jean‐Michel Vernier is often cited by papers focused on Neuroscience and Neuropharmacology Research (15 papers), Receptor Mechanisms and Signaling (12 papers) and Nicotinic Acetylcholine Receptors Study (6 papers). Jean‐Michel Vernier collaborates with scholars based in United States, France and Italy. Jean‐Michel Vernier's co-authors include Blake A. Rowe, Hervé Schaffhauser, Anthony B. Pinkerton, Lorrie P. Daggett, John H. Hutchinson, Linda J. Bristow, Michael F. Gardner, Laura E. Chavez-Noriega, Mark A. Varney and Dana E. Rodriguez and has published in prestigious journals such as Cancer Research, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Jean‐Michel Vernier

29 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean‐Michel Vernier United States	17	598	440	201	71	67	29	869
Daniele Pala Italy	19	461 0.8×	271 0.6×	216 1.1×	78 1.1×	96 1.4×	37	862
David L. Roman United States	21	762 1.3×	241 0.5×	58 0.3×	53 0.7×	81 1.2×	55	1.2k
Gunnar Nordvall Sweden	19	496 0.8×	358 0.8×	192 1.0×	70 1.0×	77 1.1×	44	812
Andrew S. Felts United States	20	447 0.7×	385 0.9×	222 1.1×	101 1.4×	24 0.4×	35	796
Ryoko Yoshikawa Japan	15	435 0.7×	481 1.1×	258 1.3×	135 1.9×	41 0.6×	19	972
Methvin Isaac Canada	20	604 1.0×	251 0.6×	543 2.7×	59 0.8×	120 1.8×	42	1.2k
Patrice Talaga Belgium	14	405 0.7×	267 0.6×	216 1.1×	71 1.0×	41 0.6×	26	924
Filomena Mattner Australia	17	485 0.8×	297 0.7×	115 0.6×	35 0.5×	190 2.8×	42	985
Anjana Sinha United States	14	391 0.7×	144 0.3×	300 1.5×	90 1.3×	30 0.4×	22	1.2k
Philip A. S. Lowden United Kingdom	14	966 1.6×	527 1.2×	227 1.1×	196 2.8×	77 1.1×	23	1.4k

Countries citing papers authored by Jean‐Michel Vernier

Since Specialization

Citations

This map shows the geographic impact of Jean‐Michel Vernier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Michel Vernier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Michel Vernier more than expected).

Fields of papers citing papers by Jean‐Michel Vernier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Michel Vernier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Michel Vernier. The network helps show where Jean‐Michel Vernier may publish in the future.

Co-authorship network of co-authors of Jean‐Michel Vernier

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Michel Vernier. A scholar is included among the top collaborators of Jean‐Michel Vernier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Michel Vernier. Jean‐Michel Vernier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagasawa, Johnny, Jenny Z. Song, Huanming Chen, et al.. (2010). 6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(2). 760–763. 22 indexed citations

Iverson, Cory, Gary Larson, Chon Lai, et al.. (2009). RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer. Cancer Research. 69(17). 6839–6847. 153 indexed citations

Hamatake, Robert, Li‐Tain Yeh, Hong Kim, et al.. (2007). RDEA119: A potent and highly selective MEK inhibitor for the treatment of cancer. Molecular Cancer Therapeutics. 6. 3 indexed citations

Pinkerton, Anthony B., Rowena V. Cube, John H. Hutchinson, et al.. (2006). Diaryl substituted pyrazoles as potent CCR2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(3). 807–813. 26 indexed citations

Govek, Steven P., Céline Bonnefous, John H. Hutchinson, et al.. (2005). Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): Efficacy in an animal model for schizophrenia. Bioorganic & Medicinal Chemistry Letters. 15(18). 4068–4072. 35 indexed citations

Bonnefous, Céline, Jean‐Michel Vernier, John H. Hutchinson, et al.. (2005). Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptor. Bioorganic & Medicinal Chemistry Letters. 15(19). 4354–4358. 36 indexed citations

Cube, Rowena V., Jean‐Michel Vernier, John H. Hutchinson, et al.. (2005). 3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy}phenyl)propanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2). Bioorganic & Medicinal Chemistry Letters. 15(9). 2389–2393. 18 indexed citations

Kamenecka, Theodore M., Céline Bonnefous, Steven P. Govek, et al.. (2005). Dipyridyl amines: Potent metabotropic glutamate subtype 5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(19). 4350–4353. 7 indexed citations

Bonnefous, Céline, et al.. (2004). Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(4). 1197–1200. 25 indexed citations

10.

Pinkerton, Anthony B., Rowena V. Cube, John H. Hutchinson, et al.. (2004). Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-Thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators. Bioorganic & Medicinal Chemistry Letters. 14(23). 5867–5872. 14 indexed citations

11.

Pinkerton, Anthony B., Rowena V. Cube, John H. Hutchinson, et al.. (2004). Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones. Bioorganic & Medicinal Chemistry Letters. 14(21). 5329–5332. 23 indexed citations

12.

Hu, Essa, Peter Chua, Lida Tehrani, et al.. (2004). Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptor. Bioorganic & Medicinal Chemistry Letters. 14(20). 5071–5074. 12 indexed citations

13.

Rao, Tadimeti S., Aida Sacaan, Frédérique Menzaghi, et al.. (2004). Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine. Brain Research. 1003(1-2). 42–53. 7 indexed citations

14.

Schaffhauser, Hervé, Blake A. Rowe, Laura E. Chavez-Noriega, et al.. (2003). Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2. Molecular Pharmacology. 64(4). 798–810. 137 indexed citations

15.

Wang, Bowei, Jean‐Michel Vernier, Sara Rao, et al.. (2003). Discovery of novel modulators of metabotropic glutamate receptor subtype-5. Bioorganic & Medicinal Chemistry. 12(1). 17–21. 24 indexed citations

16.

Lorrain, Daniel S., Hervé Schaffhauser, Una C. Campbell, et al.. (2003). Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge. Neuropsychopharmacology. 28(9). 1622–1632. 78 indexed citations

17.

Rao, Tadimeti S., Richard T. Reid, Lucia Correa, et al.. (2003). In vivo pharmacological characterization of (±)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies. Brain Research. 986(1-2). 71–81. 14 indexed citations

18.

Cosford, Nicholas D. P., Leo Bleicher, Jean‐Michel Vernier, et al.. (2000). Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist. Pharmaceutica Acta Helvetiae. 74(2-3). 125–130. 20 indexed citations

19.

Vernier, Jean‐Michel, Nicholas D. P. Cosford, Jeffrey P. Whitten, et al.. (1998). Conformationally restricted analogues of nicotine and anabasine. Bioorganic & Medicinal Chemistry Letters. 8(16). 2173–2178. 34 indexed citations

20.

Vernier, Jean‐Michel, et al.. (1996). Neuronal Nicotinic Acetylcholine Receptor Agonists. Current Pharmaceutical Design. 2(4). 357–366. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact